Patient leaflets and SmPCs, drug interaction checker, official dosages and NHS pharmacy opening hours — all in one place.
Patient leaflets and SmPCs, drug interaction checker, official dosages and NHS pharmacy opening hours — all in one place.
The electronic medicines compendium (emc) no longer publishes a Summary of Product Characteristics for this product, which usually means it is no longer marketed in the UK. The patient leaflet below is kept for reference, but the product may not be available.
If you were prescribed this medicine, other products containing Amorolfine hydrochloride may still be available. Do not stop your treatment — ask your pharmacist or GP what to use instead.
e Amorolfine 5% w/v Medicated nail lacquer Do not use Amorolfine 5% w/v Medicated nail lacquer if you are:
Pregnancy and breast-feeding You should not use Amorolfine 5% w/v Medicated nail lacquer and tell your doctor if you are pregnant or planning to be pregnant or are breast-feeding. Your doctor will then decide whether you should use this medicine. Ask your doctor or pharmacist for advice before taking any medicine.
Amorolfine 5% w/v Medicated nail lacquer Always use this medicine exactly as your doctor has told you. Check with your doctor or pharmacist if you are not sure. Amorolfine 5% w/v Medicated nail lacquer should be applied to the affected finger or toe nails once or twice a week exactly as directed by your doctor.
Step 1
Step 2
Step 3
Step 4
55
60
5
50
10
45
15
40
Step 5
20 35
30
25
Step 6
Instructions for use Step 1. File the nail Before the first application, file down the infected areas of nail, including the nail surface, as much as possible using the nail file provided. CAUTION: Do not use nail files used for infected nails on healthy nails, otherwise you may spread the infection. To prevent the spread of infection take care that no one else uses the files from your kit.
Step 2. Clean the nail Use one of the swabs provided to clean the nail surface. Repeat steps 1 and 2 for each affected nail. Step 3. Take some lacquer from the bottle Dip one of the re-usable applicators into the bottle of nail lacquer. The lacquer must NOT be wiped off on the edge of the bottle before it is applied. Step 4. Apply the lacquer Apply the nail lacquer evenly over the entire surface of the nail. Repeat steps 3 and 4 for each affected nail. Step 5. Allow to dry Let the treated nail(s) dry for approximately 3 minutes. Wait at least 10 minutes before applying cosmetic nail varnish. Step 6. Clean the applicator The applicators provided are re-useable. However, it is important to clean them thoroughly after each treatment procedure, using the same swab you used for nail cleansing. Avoid touching newly treated nails with the swab. Close the nail lacquer bottle tightly. Dispose of the swab carefully as it is inflammable.
If you get Amorolfine 5% w/v Medicated nail lacquer in your eyes or ears If you get Amorolfine 5% w/v Medicated nail lacquer in your eyes or ears wash out with water immediately and contact your doctor, pharmacist or nearest hospital straight away. If you accidentally swallow Amorolfine 5% w/v Medicated nail lacquer If you, or anyone else, accidentally swallows the lacquer contact your doctor, pharmacist or nearest hospital straight away. If you forget to use Amorolfine 5% w/v Medicated nail lacquer Don't worry if you forget to use Amorolfine 5% w/v Medicated nail lacquer at the right time. When you remember, start using the product again, in the same way as before. If you stop using Amorolfine 5% w/v Medicated nail lacquer Do not stop using Amorolfine 5% w/v Medicated nail lacquer before your doctor tells you to or your infection could come back. If you have any further questions on the use of this product, ask your doctor or pharmacist.
4 Possible side effects Like all medicines, this medicine can cause
, although not everybody gets them. In addition to the beneficial effects of Amorolfine 5% w/v Medicated nail lacquer, it is possible that unwanted effects will occur during treatment, even when it is used as directed. Rare: may affect up to 1 in 1,000 people
continued overleaf
Not known: frequency cannot be estimated from the available data
Amorolfine 5% w/v Medicated nail lacquer Keep this medicine out of the sight and reach of children. Do not use Amorolfine 5% w/v Medicated nail lacquer after the expiry date which is stated on the pack. The expiry date refers to the last day of that month. Keep the pack away from heat and keep the bottle tightly closed after use. This product is flammable. Keep the solution away from fire and flames. Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.
What Amorolfine 5% w/v Medicated nail lacquer contains
Artwork for: Product name: Size: PL/PA no: Type: Artwork dimensions: Profile supplied: Date of first artwork: Reason for request: Version no: Date of revision: Colours: Font(s): Artwork software: BAC ref:
Aspire Pharma Limited Amorolfine 5% nail lacquer POM Leaflet 212mm x 300mm Dimensions supplied 18 March 2010 Text correction 5.3 7 September 2017 As swatch(es) Text 9pt Strada Pro Condensed InDesign CS6 R600 (formerly P371)
Black
The active substance in Amorolfine 5% w/v Medicated Nail Lacquer is amorolfine hydrochloride.
Medicines with the same active substance, strength and form include: Boots Fungal Nail Once Weekly Treatment 5% w/v Medicated Nail Lacquer, Care Antifungal 5% w/v Medicated Nail Lacquer, Curanail 5% w/v Medicated Nail Lacquer. In total there are 6 equivalent products. They are interchangeable only if your prescriber or pharmacist says so.
This leaflet reproduces the patient information leaflet approved for Amorolfine 5% w/v Medicated Nail Lacquer, as published on the electronic medicines compendium (emc). The version printed inside your medicine’s packaging is the one that applies to you.
Whether a medicine is available over the counter or on prescription only depends on its licence. Check the leaflet, or ask your pharmacist — they can tell you straight away.
The text above reproduces the patient information leaflet approved for this medicine, restructured for easier reading.
Onychomycoses caused by dermatophytes, yeasts and moulds.
Adults and Elderly
The nail lacquer should be applied to the affected finger or toe nails once weekly. Twice weekly application may prove beneficial in some cases.
The patient should apply the nail lacquer as follows:
1. Before the first application Amorolfine 5% w/v Medicated nail lacquer, it is essential that the affected areas of nail (particularly the nail surfaces) should be filed down as thoroughly as possible using the nail file supplied. The surface of the nail should then be cleansed and degreased using a cleaning pad (as supplied).
Cosmetic nail lacquer may be applied at least 10 min after amorolfine 5% nail lacquer application.
Before repeat application of Amorolfine 5% w/v Medicated nail lacquer, any remaining nail lacquer, and cosmetic nail lacquer if any, should be removed carefully, then the affected nails should be filed down again as required and cleansed with an alcohol soaked swab to remove any remaining lacquer.
Caution: Nail files used for affected nails must not be used for healthy nails.
2. With one of the reusable applicators supplied, apply the nail lacquer to the entire surface of the affected nails and allow it to dry. After use, clean the applicator with the same cleaning pad used before for nail cleaning. Keep the bottle tightly closed.
For each nail to be treated, dip the applicator into the nail lacquer without wiping off any of the lacquer on the bottle neck.
Caution: When working with organic solvents (thinners, white spirit, etc.) wear impermeable gloves in order to protect the Amorolfine 5% w/v Medicated nail lacquer on the nails.
Treatment should be continued without interruption until the nail is regenerated and the affected areas are finally cured. The required frequency and duration of treatment depends essentially on intensity and localisation of the infection. In general, it is six months (finger nails) and nine to twelve months (toe nails). A review of the treatment is recommended at intervals of approximately three months.
Co-existent tinea pedis should be treated with an appropriate antimycotic cream.
Elderly
There are no specific dosage recommendations for use in elderly patients.
Paediatric population
There are no specific dosage recommendations for children owing to the lack of clinical experience available to date.
Hypersensitivity to the active substance or to any of the excipients listed in section 6.1.
Amorolfine 5% Medicated nail lacquer should not be applied on the skin around the nail.
Avoid contact of the lacquer with eyes, ears and mucous membranes.
Owing to the lack of clinical experience available to date, children should not be treated with amorolfine 5% nail lacquer.
During the application of amorolfine no artificial nails shall be used.
After applying amorolfine 5% nail lacquer, an interval of at least 10 min should be respected before application of any cosmetic nail lacquer.
Before repeat application of amorolfine 5% nail lacquer, the cosmetic nail lacquer should be removed carefully.
When organic solvents are used impermeable gloves shall be used otherwise amorolfine nail lacquer will be removed.
A systemic or local allergic reaction could possibly occur after use of this product. If this happens, the product should be stopped immediately and medical advice should be sought.
Remove the product carefully by using a nail remover solution.
The product should not be reapplied.
No interaction studies have been performed.
Use of artificial nails should be avoided during treatment.
Experience with amorolfine use during pregnancy and/or lactation is limited. Only a few cases of exposure to topical amorolfine use in pregnant women have been reported in the post-authorisation setting, therefore the potential risk is unknown. Studies in animals have shown reproductive toxicity at high oral doses; it is unknown whether amorolfine is excreted in human milk. Amorolfine should not be used during pregnancy and/or lactation unless clearly necessary.
None.
Adverse drug reactions are rare. Nail disorders (e.g. nail discoloration, broken nails, brittle nails) may occur. These reactions can also be linked to the onychomycosis itself.
System Organ Class
Frequency
Adverse drug reaction
Immune system disorders
Unknown frequency*
Hypersensitivity (systemic allergic reaction)*
Skin and subcutaneous tissue disorders
Rare (≥ 1/10000, <1/1000)
Nail disorder, nail discoloration, onychoclasis (broken nails), onychorrhexis (brittle nails)
Very rare (<1/10000)
Skin burning sensation
Unknown frequency
Erythema*, pruritus*, contact dermatitis*, urticaria*, blister*
* Post marketing experience
Reporting of suspected adverse reactions
Reporting suspected adverse reaction after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via the Yellow Card Scheme. Website: www.mhra.gov.uk/yellowcard
No systemic signs of overdose are expected following topical application of amorolfine 5% nail lacquer.
In case of accidental oral ingestion, appropriate symptomatic measures should be taken if needed.
Ask anything about Amorolfine 5% w/v Medicated Nail Lacquer. The assistant answers only from this leaflet — if the leaflet does not cover it, it will say so. It does not give medical advice.
Answers come from the patient leaflet published on the electronic medicines compendium (emc). They are not medical advice. Ask a pharmacist or your GP if you are unsure. For urgent help call NHS 111, or 999 in an emergency.
We use essential cookies to make the site work. We would also like to set optional cookies to understand how the site is used, so we can improve it. We will not set optional cookies unless you accept. See our cookie policy and privacy policy.